Company Filing History:
Years Active: 2009-2010
Title: Innovations and Contributions of Inventor Hana Stepankova
Introduction
Hana Stepankova is a notable inventor based in Cesky Brod, Czech Republic. She has made significant contributions to the field of pharmaceuticals, particularly in the development of methods related to clopidogrel, a medication used to prevent blood clots. With a total of 3 patents to her name, her work has had a meaningful impact on the industry.
Latest Patents
Hana Stepankova's latest patents include innovative methods for the racemization of the R(−) isomer of clopidogrel and the manufacturing of crystalline forms of clopidogrel hydrogen sulfate. The first patent details a method for converting the R(−) isomer into the S(+) isomer using various organic solvents and bases. The second patent outlines a process for producing clopidogrel hydrogen sulfate in crystalline form, utilizing specific solvents to achieve the desired product.
Career Highlights
Throughout her career, Hana has worked with prominent companies such as Zentiva K.s. and Zentiva A.s. Her experience in these organizations has allowed her to refine her skills and contribute to important pharmaceutical advancements.
Collaborations
Hana has collaborated with esteemed colleagues, including Josef Hajicek and Miroslav Veverka. These partnerships have fostered a collaborative environment that has led to innovative solutions in her field.
Conclusion
Hana Stepankova's contributions to the pharmaceutical industry through her patents and collaborations highlight her role as a significant inventor. Her work continues to influence the development of important medications, showcasing the impact of innovation in healthcare.